Legend: 
= Applied Session,

= Theme Session,

= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
285
|
Tue, 8/8/06, 10:30 AM - 12:20 PM
|
CC-612
|
|
Sample Size - Contributed - Papers
|
Biopharmaceutical Section
|
|
Chair(s): Tom Kelleher, Bristol-Myers Squibb Company
|
|
10:35 AM
|
Sample Size Considerations in Noninferiority Trials — Qi Jiang, Amgen Inc.; Steven Snapinn, Amgen Inc.
|
|
10:50 AM
|
Determining Sample Size for Proportions When the Information on a Prognostic Factor Is Unavailable — Bong S. Kim, Neumann College
|
|
11:05 AM
|
Sample Size Re-estimation in a Dose-Response Study — Kazuhiko Kuribayashi, Pfizer Inc.; Mike D. Smith, Pfizer Inc.
|
|
11:20 AM
|
Sample-Size Estimation for Repeated Measures Analysis in Randomized Clinical Trials with Missing Data — Kaifeng Lu, Merck & Co., Inc.; Xiaohui Luo, Merck & Co., Inc.; Pei-Yun Chen, Merck & Co., Inc.
|
|
11:35 AM
|
Sample-Size Calculations in Logistic Regression: Commnets on Hsieh, Bloch, and Larsen's Method — Mohammed K. Alam, University of Cincinnati; Marepalli Rao, University of Cincinnati; Rupa Mitra, Minnesota State University
|
|
11:50 AM
|
Extracting Information from an Ongoing Blinded Trial — Jitendra Ganju, BiostatWorks
|
|
12:05 PM
|
Floor Discussion
|
| |